Apical root-end filling with tricalcium silicate-based cement in a patient with diabetes mellitus: A case report

  • Vladimir M Biočanin Department of Dentistry, Faculty of Pharmacy and Health, University of Travnik, Travnik, Bosnia and Herzegovina, and Private Practice, Belgrade, Serbia
  • Marija Milić Clinic of Oral Surgery, Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
  • Milan Vučetić Clinic of Oral Surgery,Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
  • Miljana Baćević Clinic of Oral Surgery, Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
  • Dina Vasović Clinic of Oral Surgery,Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
  • Milka Živadinović Clinic of Oral Surgery,Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
  • Dejan Cetković Anatomy Institute, Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
  • Dejan Čalasan Clinic of Oral Surgery, Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
  • Božidar Brković Clinic of Oral Surgery, Faculty of Dental Medicine, University of Belgrade, Belgrade, Serbia
Keywords: periapical diseases, oral surgical procedures, dental cements, silicates, diabetes mellitus, type 2, comorbidity, diabetic neuropathies,

Abstract


Introduction. The material used for root-end filling has to be biocompatible with adjacent periapical tissue and to stimulate its regenerative processes. Tricalcium silicate cement (TSC), as a new dental material, shows good sealing properties with dentin, high compression strengths and better marginal adaptation than commonly used root-end filling materials. Although optimal postoperative healing of periapical tissues is mainly influenced by characteristics of end-root material used, it could sometimes be affected by the influence of systemic diseases, such as diabetes mellitus (DM). Case report. We presented apical healing of the upper central incisor, retrofilled with TSC, in a diabetic patient (type 2 DM) with peripheral neuropathy. Standard root-end resection of upper central incisor was accompanied by retropreparation using ultrasonic retrotips to the depth of 3 mm and retrofilling with TSC. Postoperatively, the surgical wound healed uneventfully. However, the patient reported undefined dull pain in the operated area that could possibly be attributed to undiagnosed intraoral diabetic peripheral neuropathy, what was evaluated clinically. Conclusion. Although TSC presents a suitable material for apical root-end filling in the treatment of chronic periradicular lesions a possible presence of systemic diseases, like type 2 DM, has to be considered in the treatment outcome estimation.

 

 

References

Chong BS, Pitt FT. Root-end filling materials: rationale and tis-sue response. Endodontic Topics 2005; 11(1): 114−30.

Han L, Okiji T. Uptake of calcium and silicon released from calcium silicate-based endodontic materials into root canal dentine. Int Endod J 2011; 44(12): 1081−7.

Wälivaara D, Abrahamsson P, Isaksson S, Salata LA, Sennerby L, Dahlin C. Periapical tissue response after use of intermediate restorative material, gutta-percha, reinforced zinc oxide ce-ment, and mineral trioxide aggregate as retrograde root-end filling materials: A histologic study in dogs. J Oral Maxillofac Surg 2012; 70(9): 2041−7.

Lima SM, Grisi DC, Kogawa EM, Franco OL, Peixoto VC, Gon-çalves-Júnior JF, et al. Diabetes mellitus and inflammatory pulpal and periapical disease: A review. Int Endod J 2013; 46(8): 700−9.

Koubi G, Colon P, Franquin J, Hartman A, Richard G, Faure MO, et al. Clinical evaluation of the performance and safety of a new dentine substitute, Bio dentine, in the restoration of posterior teeth-prospective study. Clin Oral Invest 2013;17:243-249.

Grech L, Mallia B, Camilleri J. Characterization of set Intermedi-ate Restorative Material, Biodentine, Bioaggregate and a proto-type calcium silicate cement for use as root-end filling materi-als. Int Endod J 2013; 46(7): 632−41.

Atmeh AR, Chong EZ, Richard G, Festy F, Watson TF. Dentin-cement interfacial interaction: Calcium silicates and poly-alkenoates. J Dent Res 2012; 91(5): 454−9.

Ravichandra PV, Vemisetty H, Deepthi K, Reddy JS, Ramkiran D, Krishna JN, et al. Comparative evaluation of marginal adapta-tion of Biodentine(TM) and other commonly used root end filling materials: An invitro study. J Clin Diagn Res 2014; 8(3): 243−5.

Chaudhary SB, Liporace FA, Gandhi A, Donley BG, Pinuz MS, Lin SS. Complications of ankle fracture in patients with diabetes. J Am Academy Orthop Surg 2008; 16(3): 159−70.

Kotsovilis S, Karoussis IK, Fourmousis I. A comprehensive and critical review of dental implant placement in diabetic animals and patients. Clin Oral Implants Res 2006; 17(5): 587−99.

Verhaeghe J, Herck E, Visser WJ, Suiker AM, Thomasset M, Einhorn TA, et al. Bone and mineral metabolism in BB rats with long-term diabetes: Decreased bone turnover and osteoporosis. Diabetes 1990; 39(4): 477−82.

Devlin H, Garland H, Sloan P. Healing of tooth extraction sock-ets in experimental diabetes mellitus. Journal of oral and maxil-lofacial surgery 1996; 54(9): 1087−91.

Tooke JE. Microvascular function in human diabetes: A physiological perspective. Diabetes 1995; 44(7): 721−6.

Malik RA, Veves A, Masson EA, Sharma AK, Ah-See AK, Schady W, et al. Endoneurial capillary abnormalities in mild human di-abetic neuropathy. J Neurol Neurosurg Psychiatr 1992; 55(7): 55−61.

Lin JH, Duffy JL, Roginsky MS. Microcirculation in diabetes mellitus: A study of gingival biopsies. Hum Pathol 1975; 6(1): 77−96.

Torabinejad M, Chivian N. Clinical applications of mineral triox-ide aggregate. J Endod 1999; 25(3): 197−205.

Torabinejad M, Rastegar AF, Kettering JD, Pitt FT. Bacterial leak-age of mineral trioxide aggregate as a root-end filling material. J Endod 1995; 21(3): 109−12.

Torabinejad M, Watson TF, Pitt FT. Sealing ability of a mineral trioxide aggregate when used as a root end filling material. J Endod 1993; 19(12): 591−5.

Torabinejad M, Smith PW, Kettering JD, Pitt FT. Comparative in-vestigation of marginal adaptation of mineral trioxide aggre-gate and other commonly used root-end filling materials. J Endod 1995; 21(6): 295−9.

Hakki SS, Bozkurt BS, Hakki EE, Belli S. Effects of mineral trioxide aggregate on cell survival, gene expression associated with mineralized tissues, and biomineralization of cemento-blasts. J Endod 2009; 35(4): 513−9.

Zanini M, Sautier JM, Berdal A, Simon S. Biodentine induces immortalized murine pulp cell differentiation into odontoblast-like cells and stimulates biomineralization. J Endod 2012; 38(9): 1220−6.

Tran XV, Gorin C, Willig C, Baroukh B, Pellat B, Decup F, et al. Effect of a calcium-silicate-based restorative cement on pulp repair. J Dent Res 2012;1(12): 1166−71.

Laurent P, Camps J, About I. Biodentine(TM) induces TGF-β1 release from human pulp cells and early dental pulp minerali-zation. Int Endod J 2012; 45(5): 439−48.

Lee B, Lee K, Koh J, Min K, Chang H, Hwang I, et al. Effects of 3 endodontic bioactive cements on osteogenic differentiation in mesenchymal stem cells. J Endod 2014; 40(8): 1217−22.

Pawar AM, Kokate SR, Shah RA. Management of a large periapical lesion using Biodentine(™) as retrograde restoration with eighteen months evident follow up. J Conserv Dent 2013; 16(6): 573−5.

Butt N, Talwar S, Chaudhry S, Nawal RR, Yadav S, Bali A. Com-parison of physical and mechanical properties of mineral trioxide aggregate and Biodentine. Indian J Dent Res 2014; 25(6): 692−7.

Bhavana V, Chaitanya KP, Gandi P, Patil J, Dola B, Reddy RB. Evaluation of antibacterial and antifungal activity of new calci-um-based cement (Biodentine) compared to MTA and glass ionomer cement. J Conserv Dent 2015; 18(1): 44−6.

Collin HL, Niskanen L, Uusitupa M, Toyry J, Collin P, Koivisto AM, et al. Oral symptoms and signs in elderly patients with type 2 diabetes mellitus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2000; 90(3): 299−305.

Moore PA, Guggenheimer J, Orchard T. Burning mouth syndrome and peripheral neuropathy in patients with type 1 diabetes mellitus. J Diabetes Complicat 2007; 21(6): 397−402.

Brull R, McCartney CJ, Chan VW, Liguori GA, Hargett MJ, Xu D, et al. Disclosure of risks associated with regional anesthesia: A survey of academic regional nesthesiologists. Reg Anesth Pain Med 2007; 32(1): 7−11.

Hebl JR, Kopp SL, Schroeder DR, Horlocker TT. Neurologic com-plications after neuraxial anesthesia or analgesia in patients with preexisting peripheral sensorimotor neuropathy or diabetic polyneuropathy. Anesth Analg 2006; 103(5): 1294−9.

Pfaffenrath V, Rath M, Pöllmann W, Keeser W. Atypical facial pain: application of the IHS criteria in a clinical sample. Cephalalgia 1993; 13(Suppl 12): 84−8.

Zebenholzer K, Wöber C, Vigl M, Wessely P, Wöber-Bingöl C. Facial pain and the second edition of the International Classification of Headache Disorders. Headache 2006; 46(2): 259−63.

Published
2017/03/14
Section
Case report